tradingkey.logo

tradingkey.logo
怜玢


P3 Health Partners Inc

PIII
りォッチリストに远加
4.010USD
+0.440+12.32%
取匕時間 ET15分遅れの株䟡
13.10M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 P3 Health Partners Inc 䌁業名

P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.

P3 Health Partners Incの䌁業情報


䌁業コヌドPIII
䌚瀟名P3 Health Partners Inc
䞊堎日Feb 10, 2021
最高経営責任者「CEO」Coffman (Aric)
埓業員数360
蚌刞皮類Ordinary Share
決算期末Feb 10
本瀟所圚地2045 W Grand Ave Ste B
郜垂CHICAGO
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号60612-1577
電話番号13128228897
りェブサむトhttps://ir.p3hp.org/
䌁業コヌドPIII
䞊堎日Feb 10, 2021
最高経営責任者「CEO」Coffman (Aric)

P3 Health Partners Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Amir Bacchus, M.D.
Dr. Amir Bacchus, M.D.
Co-Founder, Chief Medical Officer, Director
Co-Founder, Chief Medical Officer, Director
45.13K
--
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
21.36K
+9.36%
Mr. Mark Alan Thierer
Mr. Mark Alan Thierer
Independent Chairman of the Board
Independent Chairman of the Board
16.85K
+23.74%
Ms. Mary A. Tolan
Ms. Mary A. Tolan
Independent Director
Independent Director
4.17K
+48.01%
Mr. Gregory N. (Greg) Kazarian
Mr. Gregory N. (Greg) Kazarian
Director
Director
4.17K
+48.01%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Independent Director
Independent Director
4.17K
+48.01%
Mr. Lawrence B. (Larry) Leisure
Mr. Lawrence B. (Larry) Leisure
Independent Director
Independent Director
--
--
Dr. Thomas E. (Tom) Price, M.D.
Dr. Thomas E. (Tom) Price, M.D.
Independent Director
Independent Director
--
--
Dr. Aric Coffman, M.D.
Dr. Aric Coffman, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Ryan Halstead
Mr. Ryan Halstead
Managing Director
Managing Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Amir Bacchus, M.D.
Dr. Amir Bacchus, M.D.
Co-Founder, Chief Medical Officer, Director
Co-Founder, Chief Medical Officer, Director
45.13K
--
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
21.36K
+9.36%
Mr. Mark Alan Thierer
Mr. Mark Alan Thierer
Independent Chairman of the Board
Independent Chairman of the Board
16.85K
+23.74%
Ms. Mary A. Tolan
Ms. Mary A. Tolan
Independent Director
Independent Director
4.17K
+48.01%
Mr. Gregory N. (Greg) Kazarian
Mr. Gregory N. (Greg) Kazarian
Director
Director
4.17K
+48.01%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Independent Director
Independent Director
4.17K
+48.01%

収益内蚳

FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United States
1.46B
0.00%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, May 10
曎新時刻: Sun, May 10
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Chicago Pacific Founders UGP LLC
46.52%
Alyeska Investment Group, L.P.
4.14%
Vanguard Capital Management, LLC
2.13%
Bacchus (Amir)
1.36%
Abdou (Sherif)
0.97%
他の
44.88%
株䞻統蚈
株䞻統蚈
比率
Chicago Pacific Founders UGP LLC
46.52%
Alyeska Investment Group, L.P.
4.14%
Vanguard Capital Management, LLC
2.13%
Bacchus (Amir)
1.36%
Abdou (Sherif)
0.97%
他の
44.88%
皮類
株䞻統蚈
比率
Corporation
46.52%
Investment Advisor
4.76%
Individual Investor
4.23%
Hedge Fund
4.14%
Investment Advisor/Hedge Fund
0.65%
Research Firm
0.11%
他の
39.58%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
124
396.96K
11.99%
-388.51K
2025Q4
132
360.78K
10.98%
-427.31K
2025Q3
140
358.16K
10.96%
-476.81K
2025Q2
159
2.39M
73.22%
-351.07K
2025Q1
163
2.40M
73.55%
-322.33K
2024Q4
164
121.70M
75.84%
-21.19M
2024Q3
165
70.21M
46.23%
-6.58M
2024Q2
165
74.96M
49.19%
+19.75M
2024Q1
158
50.37M
43.55%
+5.90M
2023Q4
154
52.28M
45.78%
+2.36M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Chicago Pacific Founders UGP LLC
1.54M
46.86%
--
--
Jun 04, 2025
Alyeska Investment Group, L.P.
137.41K
4.17%
-43.50K
-24.05%
Dec 31, 2025
Bacchus (Amir)
45.13K
1.37%
--
--
Apr 09, 2025
Abdou (Sherif)
32.16K
0.98%
--
--
Apr 09, 2025
Trinity Financial Advisors LLC
28.66K
0.87%
+1.98K
+7.42%
Dec 31, 2025
Geode Capital Management, L.L.C.
21.41K
0.65%
+1.03K
+5.06%
Dec 31, 2025
Wasson (Gregory D)
21.36K
0.65%
+2.00K
+10.33%
Aug 06, 2025
Corient Private Wealth LLC
20.84K
0.63%
-14.53K
-41.09%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
比率0%
ProShares Hedge Replication ETF
比率0%
Global X Russell 2000 ETF
比率0%
Global X Russell 2000 Covered Call ETF
比率0%
Proshares Ultra Russell 2000
比率0%
iShares Micro-Cap ETF
比率0%
Fidelity Nasdaq Composite Index ETF
比率0%
iShares Russell 2000 Growth ETF
比率0%
iShares Russell 2000 ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Apr 04, 2025
Merger
50→1
日付
配圓萜ち日
皮類
比率
Apr 04, 2025
Merger
50→1
KeyAI
î™